Abstract
IntroductionThe approved dose for infliximab (IFX) in the treatment of ankylosing spondylitis (AS) is 5 mg/kg body weight every 6 weeks. Several studies have shown the 3 mg/kg dose to...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
